190 related articles for article (PubMed ID: 16557045)
1. Kallikreins as markers of disseminated tumour cells in ovarian cancer-- a pilot study.
Oikonomopoulou K; Scorilas A; Michael IP; Grass L; Soosaipillai A; Rosen B; Murphy J; Diamandis EP
Tumour Biol; 2006; 27(2):104-14. PubMed ID: 16557045
[TBL] [Abstract][Full Text] [Related]
2. KLK10 exon 3 unmethylated PCR product concentration: a new potential early diagnostic marker in ovarian cancer? - A pilot study.
El Sherbini MA; Mansour AA; Sallam MM; Shaban EA; Shehab ElDin ZA; El-Shalakany AH
J Ovarian Res; 2018 Apr; 11(1):32. PubMed ID: 29690914
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer.
Alexopoulou DK; Papadopoulos IN; Scorilas A
Clin Biochem; 2013 Oct; 46(15):1453-61. PubMed ID: 23499583
[TBL] [Abstract][Full Text] [Related]
4. In-silico analysis of kallikrein gene expression in pancreatic and colon cancers.
Yousef GM; Borgoño CA; Popalis C; Yacoub GM; Polymeris ME; Soosaipillai A; Diamandis EP
Anticancer Res; 2004; 24(1):43-51. PubMed ID: 15015574
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of serum kallikrein-related peptidases 6 and 10 versus CA125 in ovarian cancer.
El Sherbini MA; Sallam MM; Shaban EA; El-Shalakany AH
Int J Gynecol Cancer; 2011 May; 21(4):625-32. PubMed ID: 21412167
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancers.
Sidiropoulos M; Pampalakis G; Sotiropoulou G; Katsaros D; Diamandis EP
Tumour Biol; 2005; 26(6):324-36. PubMed ID: 16254462
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of kallikrein 10 in epithelial ovarian carcinomas.
Shvartsman HS; Lu KH; Lee J; Lillie J; Deavers MT; Clifford S; Wolf JK; Mills GB; Bast RC; Gershenson DM; Schmandt R
Gynecol Oncol; 2003 Jul; 90(1):44-50. PubMed ID: 12821340
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of human tissue kallikrein-related peptidases 6 and 10 expression in early gastroesophageal adenocarcinoma.
Grin A; Samaan S; Tripathi M; Rotondo F; Kovacs K; Bassily MN; Yousef GM
Hum Pathol; 2015 Apr; 46(4):541-8. PubMed ID: 25649006
[TBL] [Abstract][Full Text] [Related]
9. Study of kallikrein-related peptidase 6 (KLK6) and its complex with α1-antitrypsin in biological fluids.
Korbakis D; Soosaipillai A; Diamandis EP
Clin Chem Lab Med; 2017 Aug; 55(9):1385-1396. PubMed ID: 28672746
[TBL] [Abstract][Full Text] [Related]
10. Kallikrein family proteases KLK6 and KLK7 are potential early detection and diagnostic biomarkers for serous and papillary serous ovarian cancer subtypes.
Tamir A; Jag U; Sarojini S; Schindewolf C; Tanaka T; Gharbaran R; Patel H; Sood A; Hu W; Patwa R; Blake P; Chirina P; Oh Jeong J; Lim H; Goy A; Pecora A; Suh KS
J Ovarian Res; 2014 Dec; 7():109. PubMed ID: 25477184
[TBL] [Abstract][Full Text] [Related]
11. Copy number and expression alterations of miRNAs in the ovarian cancer cell line OVCAR-3: impact on kallikrein 6 protein expression.
Bayani J; Kuzmanov U; Saraon P; Fung WA; Soosaipillai A; Squire JA; Diamandis EP
Clin Chem; 2013 Jan; 59(1):296-305. PubMed ID: 23136250
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of human kallikrein 10 gene expression in colorectal cancer and gastric cancer.
Feng B; Xu WB; Zheng MH; Ma JJ; Cai Q; Zhang Y; Ji J; Lu AG; Qu Y; Li JW; Wang ML; Hu WG; Liu BY; Zhu ZG
J Gastroenterol Hepatol; 2006 Oct; 21(10):1596-603. PubMed ID: 16928223
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer.
Kyriakopoulou LG; Yousef GM; Scorilas A; Katsaros D; Massobrio M; Fracchioli S; Diamandis EP
Clin Biochem; 2003 Mar; 36(2):135-43. PubMed ID: 12633763
[TBL] [Abstract][Full Text] [Related]
14. Kallikrein-related peptidase 10 (KLK10) expression and single nucleotide polymorphisms in ovarian cancer survival.
Batra J; Tan OL; O'Mara T; Zammit R; Nagle CM; Clements JA; Kedda MA; Spurdle AB
Int J Gynecol Cancer; 2010 May; 20(4):529-36. PubMed ID: 20686372
[TBL] [Abstract][Full Text] [Related]
15. Higher human kallikrein gene 4 (KLK4) expression indicates poor prognosis of ovarian cancer patients.
Obiezu CV; Scorilas A; Katsaros D; Massobrio M; Yousef GM; Fracchioli S; Rigault de la Longrais IA; Arisio R; Diamandis EP
Clin Cancer Res; 2001 Aug; 7(8):2380-6. PubMed ID: 11489816
[TBL] [Abstract][Full Text] [Related]
16. Co-expression of KLK6 and KLK10 as prognostic factors for survival in pancreatic ductal adenocarcinoma.
Rückert F; Hennig M; Petraki CD; Wehrum D; Distler M; Denz A; Schröder M; Dawelbait G; Kalthoff H; Saeger HD; Diamandis EP; Pilarsky C; Grützmann R
Br J Cancer; 2008 Nov; 99(9):1484-92. PubMed ID: 18854834
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional upregulation of human tissue kallikrein 6 in ovarian cancer: clinical and mechanistic aspects.
Shan SJ; Scorilas A; Katsaros D; Diamandis EP
Br J Cancer; 2007 Jan; 96(2):362-72. PubMed ID: 17242704
[TBL] [Abstract][Full Text] [Related]
18. Characterization of kallikrein-related peptidase 4 (KLK4) mRNA expression in tumor tissue of advanced high-grade serous ovarian cancer patients.
Gong W; Liu Y; Seidl C; Dreyer T; Drecoll E; Kotzsch M; Bronger H; Dorn J; Magdolen V
PLoS One; 2019; 14(2):e0212968. PubMed ID: 30811511
[TBL] [Abstract][Full Text] [Related]
19. The association with age, human tissue kallikreins 6 and 10 and hemostatic markers for survival outcome from epithelial ovarian cancer.
Koh SC; Razvi K; Chan YH; Narasimhan K; Ilancheran A; Low JJ; Choolani M;
Arch Gynecol Obstet; 2011 Jul; 284(1):183-90. PubMed ID: 20680316
[TBL] [Abstract][Full Text] [Related]
20. Combined expression of KLK4, KLK5, KLK6, and KLK7 by ovarian cancer cells leads to decreased adhesion and paclitaxel-induced chemoresistance.
Loessner D; Quent VM; Kraemer J; Weber EC; Hutmacher DW; Magdolen V; Clements JA
Gynecol Oncol; 2012 Dec; 127(3):569-78. PubMed ID: 22964375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
